Institutional investors hold a majority ownership of GILD through the 86.60% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2015, these large investors purchased a net $23.0 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WALTER SCOTT & PARTNERS LTD. Bought 4.5 Million shares of Gilead Sciences
CAPITAL RESEARCH & MANAGEMENT CO... Bought 3.1 Million shares of Gilead Sciences
RENAISSANCE TECHNOLOGIES LLC Bought 3.1 Million shares of Gilead Sciences